Aims Congestive heart failure is characterized by high levels of norepinephrine which is considered to be arrhythmogenic. It is unclear whether increased norepinephrine is only a marker of the severity of heart failure or whether it directly triggers ventricular arrhythmias.
Introduction
Patients with congestive heart failure suffer frequently from ventricular arrhythmias and have a high incidence of sudden death [1, 2] . Increased plasma catecholamine levels, reflecting activation of the sympathetic nervous system, constitute an important marker of congestive heart failure [3, 4] . Norepinephrine may be an important arrhythmogenic factor in congestive heart failure although direct evidence is not available [5, 6] .
In the heart, norepinephrine affects several inwardly and outwardly directed membrane currents via both -and -adrenoceptors [7] [8] [9] [10] . The ultimate effect of these changes in individual currents on the action potential (duration) is not easy to predict. In fact experiments focused on combinations of synthetic agonists and antagonists designed to unravel detailed effects of specific receptors ( 1 , 2 , 1 , 2 , 3 ) have, at the same time, obscured the overall assessment of the effects of the native transmitters, as pointed out previously in this journal [11] . Differences between species and between conduction systems, atria and ventricles play an important role [11] . There are hardly any data on the effect of norepinephrine on the human ventricular action potential. One study reported that norepinephrine exerted no significant change on action potential duration [12] , and in another study prolongation of the action potential was reported, albeit measured at 26 C [13] . Heart failure induces a number of changes in human ventricular myocardium which may alter the electrophysiological response to norepinephrine. These changes include the density of various membrane channels [14] , down-regulation and uncoupling of -adrenoceptors, and activity of the inhibitory G-protein [15] . We investigated the effects of norepinephrine on the electrophysiology of single ventricular myocytes isolated from hearts of patients suffering from end-stage heart failure. Using the whole-cell configuration of the patch-clamp technique we studied the effects of norepinephrine on the action potential configuration and various membrane currents. In contrast to the predominance of action potential shortening following high concentrations of norepinephrine in many animal studies [11] , we demonstrate that in failing human ventricular cells norepinephrine causes a prolongation of the action potential in association with the occurrence of early afterdepolarizations. This is due to an increase in peak inward as well as window Ca 2+ current (I Ca-L ).
Methods

Preparation of single ventricular myocytes
Ventricular myocytes were isolated from explanted human hearts by an enzymatic dissociation procedure [16] with minor modifications. The hearts were obtained from eight patients with end-stage heart failure due to ischaemic (n=5) or dilated cardiomyopathy (n=3), undergoing heart transplantation. Informed consent was obtained before transplantation. At operation, all patients were in New York Heart Association class IV and had a mean ejection fraction of 20% 5% (mean SEM). Directly after explantation, the heart was transported to the laboratory in oxygenated normal Tyrode's solution I (4 C). A part of the left ventricular free wall was mounted on a Langendorff perfusion apparatus where it was perfused through a branch of the left anterior descending coronary artery with solutions in the following sequence: (1 ; recirculation). After about 30 min, the left ventricular wall was cut into small pieces and further fractionated using a standard shaking protocol [17] . Cells were stored in low calcium Tyrode's solution with 1·3 mmol . l 1 CaCl 2 and 1% albumin. The living-cell yield was about 8%. Only quiescent rod-shaped cells with clear cross striations were used. During the entire isolation procedure the solutions were oxygenated and temperature was maintained at 37 C. 
Solutions and reagents
Recording procedures
Small aliquots of cell suspension were introduced to a cell chamber placed on a temperature-controlled stage of an inverted microscope (Nikon Diaphot). The isolated myocytes were allowed to adhere to the bottom of the cell chamber for 3 min after which continuous perfusion with normal Tyrode's solution II was started at a rate of approximately 1 ml . min 1 . The temperature of the bath was maintained at 34 2 C. Membrane currents and potentials were recorded in the whole-cell configuration of the patch-clamp technique [18] with a custom made patch-clamp amplifier. The pipettes were pulled from borosilicate glass by a custom-made one-stage puller. The tips of the pipettes were heat-polished. After filling with the appropriate pipette solution the pipetteresistance was 3-5 M . The access-resistance varied between 4-12 M . Whole-cell currents and potentials were stored on digital audiotape by a digital tape recorder (DTR 1200, Biologic, Claix, France). Membrane currents were off-line filtered (low-pass) at 2 kHz with a two-pole Butterworth filter, digitized at a sampling interval of 250 s by an AD converter board (National Instruments), and stored on a hard disk of a computer (Apple Macintosh) for subsequent data analysis.
Data analysis
The amplitude of the calcium current (I Ca-L ) was measured as the difference between the peak inward current and the quasi steady-state current. The quasi steady-state current (I QSS ) was defined as the current amplitude at 500 ms after the onset of the voltage step. The amplitude of the transient outward current (I to ) was measured as the difference between the peak outward current and I QSS . Averaged data are expressed as mean standard error of the mean (SEM). Statistical significance was evaluated by the Student's t-test for paired data (two-tailed) or with ANOVA with the significance level at 0·05.
Results
Action potentials
Action potentials and membrane currents were measured in a total of 26 cells isolated from eight hearts of patients suffering from ischaemic (n=5) or dilated cardiomyopathy (n=3). The average cell capacitance of these cells was 256 25 pF. Figure 1 shows the relation between cycle length and APD90 during normal conditions in six cells from four hearts in which the cells were paced at cycle lengths between 500 to 5000 ms. The effect of 1 mol . l 1 norepinephrine was studied in 14 of the total of 26 cells from eight hearts. APD90 increased in all of them. Figure 2 (a) shows the increase of APD90 from 644 ms during standard conditions to 778 ms in the presence of 1 mol . l 1 norepinephrine in a ventricular myocyte stimulated at 1500 ms. In 50% of the cells (7 out of 14) 1 mol . l 1 norepinephrine caused a much larger increase in APD90 with concomitant early afterdepolarizations ( Fig. 2(b) ). Early afterdepolarizations always developed from a membrane potential between 0 and 20 mV. 
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length 2000 ms APD90 was 654 67·1 ms (n=14) under standard conditions (Table 1) . Interestingly, prior to the administration of norepinephrine, APD90 was longer in ventricular myocytes with early afterdepolarizations in response to 1 mol . l 1 norepinephrine (n=7) than in cells without early afterdepolarizations (n=7) (784 101·1 vs 523 60·4 ms; ANOVA P<0·05; Table 1 ). This suggests that cells with longer action potentials under standard conditions are predisposed to develop early afterdepolarizations in the presence of 1 mol . l 1 norepinephrine. Also, cells with a propensity to norepinephrine-induced early afterdepolarization had lower upstroke velocities of the action potentials under standard conditions (69 11·1 vs 112 7·5 vs; ANOVA P<0·01; Table 1 ). Ventricular myocytes without norepinephrine-induced early afterdepolarizations still showed increase of APD90 in response to 1 mol . l 1 norepinephrine, thereby excluding the occurrence of early afterdepolarizations as the underlying causal factor for the prolongation of the action potential.
Membrane currents
We examined the L-type calcium current (I Ca-L ), the quasi steady-state current (I QSS ) and the transient outward current (I to ) to determine which changes in membrane currents may underlie the observed prolongation of the action potential. To measure I Ca-L and I QSS , 1000 ms hyperpolarizing and depolarizing voltage steps were applied from a holding potential of 40 mV with 10 mV increments (frequency 0·5 Hz). The inset in Fig. 3(a) shows examples of current traces recorded during a depolarizing step from 40 mV to +10 mV with and without 1 mol . l 1 norepinephrine. In the presence of norepinephrine the peak calcium current is larger and inactivates more slowly. The time constants of inactivation were 46 5 ms at control and 65 5 ms in the presence of norepinephrine at 0 mV. Figure 3 shows the voltage-current relationship of I QSS , defined as the current amplitude at 500 ms after the onset of the voltage step. Between 40 and 0 mV this relationship is shifted in the inward direction in the presence of norepinephrine. This shift was significant at 30 mV. Although a net increase in inward current can be either due to a decrease in outward current or to an increase in inward current, an increase in calcium window current may well be the background, because I Ca-L was increased (see next section). From the fact that I QSS at voltages negative to 40 mV and positive to 0 mV was not affected by norepinephrine (Fig. 3(c) ), we assume that neither the inward rectifier current (I K1 ) nor delayed rectifier currents (I Kr and I Ks ) were affected. 
Calcium window current
The calcium window current may explain the increase in steady state current between 40 mV and 0 mV in the presence of norepinephrine as shown in Fig. 3(b) . To test this option we applied hyperpolarizing and depolarizing pulses from a holding potential of 40 mV during control conditions, in the presence of 1 mol . l 1 norepinephrine and in the presence of 1 mol . l 1 norepinephrine plus 0·25 mmol . l 1 CdCl 2 (n=4). Figure 4 (a) shows current traces recorded during voltage steps from 40 mV to 30 mV (top) and from 40 mV to +10 mV (bottom). At 30 mV, within the voltage range of the window, the current at the end of a 500 ms step is slightly outward during the control condition (Fig. 4(a) broken line). In the presence of norepinephrine the current becomes inwardly directed (Fig. 4(a) , top panel; solid circle). In the combined presence of CdCl 2 and norepinephrine, this inward shift is completely abolished (Fig. 4(a) , top panel; triangle). During a step to +10 mV, outside the voltage range of the window, the current at the end of the 500 ms step is identical under all conditions (Fig. 4(a) , bottom panel). Figure 4 (b) shows the average current voltage relationship of all four cells. In the range negative to 40 mV all curves are identical. Between 40 mV and 0 mV the currentvoltage relationship is inwardly shifted in the presence of norepinephrine, an effect which is completely reversed by the addition of CdCl 2 . Positive to +20 mV in the presence of norepinephrine and CdCl 2 , there is a marked increase in outward current, possibly a CdCl 2 -induced increase in delayed rectifier current [19] . Figure 4 (c) shows that CdCl 2 in the presence of norepinephrine strongly reduced the plateau height, shortened the action potential and abolished the early afterdepolorizations (triangle), which was provoked in the presence of norepinephrine alone (Fig. 4(c), solid circle) . Figure 5 (a) shows that 5 mmol caffeine was not able to abolish norepinephrine-induced early afterdepolarizations, as was observed in four cells from three hearts. Also, action potential prolongation persisted. In contrast, Fig. 5(b) shows that the same concentration of caffeine was effective in the prevention of delayed afterdepolarizations induced by 1 mol . l 1 norepinephrine. These results preclude an important role for the sarcoplasmic reticulum in the genesis of both action potential prolongation and early afterdepolarizations by norepinephrine.
Discussion
Norepinephrine invariably caused prolongation of the action potential in ventricular myocytes isolated from human end-stage failing hearts. In 50% of those myocytes this prolongation was accompanied by early afterdepolarizations.
Norepinephrine prolongs action potential duration in man
A high concentration of norepinephrine (1 mol . l 1 ) increases APD90 in ventricular myocytes isolated from hearts explanted from patients with end-stage heart failure in contrast to the opposite effect of norepinephrine [20] [21] [22] or epinephrine [23] [24] [25] [26] in the ventricles of many animal species. Studies on the effects of the natural transmitters in general date back many years for reasons explained previously [11] . At physiological temperature there is only one study on isolated human papillary muscle directed to inotropic effects in which both epinephrine and norepinephrine were without a significant effect on APD90 [12] . Our finding of prolongation of the action potential by norepinephrine in the human ventricle raises the important question whether this is caused by a difference between most animal species and man or by the fact that the tissue was isolated from failing hearts. In the absence of control data from normal donor hearts this question cannot be answered. The fact that the effect of sympathetic stimulation on refractoriness in the canine ventricle is opposite in normal (shortened) and ischaemic tissue (prolonged) even within the same individual [27] , underscores the significance of the underlying pathophysiology of the effect of sympathetic transmitters. An important role for underlying pathophysiology is also suggested from the observation that APD90 is longer in cells isolated from hearts with dilated cardiomyopathy compared to ischaemic cardiomyopathy [28] . From studies on the intact human heart it was previously suggested that norepinephrine shortens APD90 and it was anticipated that blockade of -adrenoceptors would prolong APD90 [29] . However, in normal subjects [30] [31] [32] as well as in patients with coronary artery disease [33] the QT corrected interval shortens after propranolol. In another study on patients with coronary artery disease, propranolol decreased monophasic APD90 [34] . These observations suggest that the -adrenoceptor mediated effect of norepinephrine is prolongation of the action potential both in the normal 
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and in the diseased heart, although it is questionable whether data on QT or QT corrected intervals can be taken as an index of action potential duration, as was discussed in a recent editorial in this journal [35] . Moreover, -adrenoceptor blockade at an unknown autonomic balance, is not the same as adding norepinephrine to tissue or cells in Tyrode's solution. Our study demonstrates, at a direct level of assessment, that norepinephrine prolongs APD90 at normal temperature in ventricular myocytes from human end-stage failing hearts.
Mechanism of action potential prolongation by norepinephrine
Voltage-clamp experiments indicated a twofold increase in the calcium current (I Ca-L ) in the presence of norepinephrine. Additionally, we observed an inward shift in the quasi steady-state (I QSS ) current in the voltage range between 0 mV and 40 mV. Two factors strongly suggest that this inward shift reflects an increase in the so-called calcium 'window' current, the maintained inward calcium current due to an overlap of activation and inactivation relationships. Functionally, this implies that I Ca-L will deliver more inward current at a membrane potential range where under normal conditions repolarization is well on its way. Firstly, the voltage range in which the inward shift in I QSS occurs is similar to that reported for the window calcium current [36] [37] [38] [39] . Secondly, the norepinephrine-induced inward shift was completely abolished by CdCl 2 , a blocker of I Ca-L . It is of interest that even in the presence of CdCl 2 there is still inward current. This may represent the recently described ultraslowly inactivating sodium current in human ventricular myocytes [40] . The increase of I Ca-L in the absence of a change in outward current complies with the observed action potential prolongation.
Early afterdepolarizations
Our study confirms the occurrence of early afterdepolarizations in human ventricular myocytes in response to -adrenoceptor stimulation [41] . Several cellular mechanisms have been implicated in the generation of early afterdepolarizations in ventricular muscle, among which are changes in I Ca-L [42] and the Na-Ca exchanger [43] . We showed that the take-off potential of the early afterdepolarizations is in the same voltage range as the inward shift in I QSS (i.e. the calcium window current). Furthermore, CdCl 2 abolishes both this window current and the early afterdepolarizations, suggesting a role for the calcium window current in the generation of early afterdepolarizations in human ventricular myocytes. Under circumstances of action potential prolongation, the action potential may remain long enough at plateau level to permit recovery from inactivation of I Ca-L during early repolarization, with subsequent reactivation of I Ca-L , resulting in transient depolarization [44, 45] .
Implications and limitations
After enzyme treatment of the left ventricular wall, a very thin layer of the epicardial surface was removed before the tissue was cut into pieces for further dissociation. The cells were from mid-and endocardial origin and also, but to a lesser extent, from epicardial origin. This may have added variability to our results.
The isolated ventricular myocytes in this study had already prolonged action potentials during control conditions, probably as a result of remodelling associated with heart failure [14] , although altered repolarization properties caused by the isolation procedure cannot be excluded. The extent to which electrophysiological abnormalities in isolated myocytes may be integrated into functional abnormalities at the organ level will depend on intercellular coupling. There are several observations on decreased intercellular coupling in heart failure, but data in combination with functional consequences are sparse [46] as pointed out recently [47] . Further prolongation by norepinephrine will render these cells susceptible to the generation of early afterdepolarizations. Since early afterdepolarizations may initiate triggered arrhythmias [48] our results point to an important role for norepinephrine in the generation of arrhythmias in congestive heart failure. Moreover, prophylactic prevention of early afterdepolarizations by f.e. class IV antiarrhythmic agents may, in particular, be effective in patients with heart failure if there are indications that action potential duration is substantially prolonged.
